Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of finasteride in men with benign prostatic hyperplasia. 1992.
Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, Vaughan ED, Pappas F, Taylor A, Binkowitz B, Ng J; Finasteride Study Group. Gormley GJ, et al. Among authors: bruskewitz rc. J Urol. 2002 Feb;167(2 Pt 2):1102-7; discussion 1108. doi: 10.1016/s0022-5347(02)80349-4. J Urol. 2002. PMID: 11905882 No abstract available.
Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia.
Lowe FC, McConnell JD, Hudson PB, Romas NA, Boake R, Lieber M, Elhilali M, Geller J, Imperto-McGinely J, Andriole GL, Bruskewitz RC, Walsh PC, Bartsch G, Nacey JN, Shah S, Pappas F, Ko A, Cook T, Stoner E, Waldstreicher J; Finasteride Study Group. Lowe FC, et al. Among authors: bruskewitz rc. Urology. 2003 Apr;61(4):791-6. doi: 10.1016/s0090-4295(02)02548-7. Urology. 2003. PMID: 12670567 Clinical Trial.
Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
Roehrborn CG, Bruskewitz R, Nickel JC, McConnell JD, Saltzman B, Gittelman MC, Malek GH, Gottesman JE, Suryawanshi S, Drisko J, Meehan A, Waldstreicher J; Proscar Long-Term Efficacy and Safety Study Group. Roehrborn CG, et al. J Urol. 2004 Mar;171(3):1194-8. doi: 10.1097/01.ju.0000112918.74410.94. J Urol. 2004. PMID: 14767299 Clinical Trial.
Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. The North American Finasteride Study Group.
Hudson PB, Boake R, Trachtenberg J, Romas NA, Rosenblatt S, Narayan P, Geller J, Lieber MM, Elhilali M, Norman R, Patterson L, Perreault JP, Malek GH, Bruskewitz RC, Roy JB, Ko A, Jacobsen CA, Stoner E. Hudson PB, et al. Among authors: bruskewitz rc. Urology. 1999 Apr;53(4):690-5. doi: 10.1016/s0090-4295(98)00666-9. Urology. 1999. PMID: 10197842 Clinical Trial.
Update on AUA guideline on the management of benign prostatic hyperplasia.
McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE Jr, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC, Wei JT. McVary KT, et al. Among authors: bruskewitz rc. J Urol. 2011 May;185(5):1793-803. doi: 10.1016/j.juro.2011.01.074. Epub 2011 Mar 21. J Urol. 2011. PMID: 21420124
Benign prostatic hyperplasia.
Bruskewitz RC. Bruskewitz RC. J Urol. 1994 Jun;151(6):1557. doi: 10.1016/s0022-5347(17)35301-6. J Urol. 1994. PMID: 7514687 No abstract available.
127 results